← Back to All Filings

Guardant Health Director Roberto Mignone Acquires 264 Shares via RSU Vesting

Low SignificanceOctober 22, 2026 at 5:44:23 PM EDT

Guardant Health, Inc.

$GH4CIK: 0001576280

Subscribe to track GH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📋 Form 4 Filing: Guardant Health, Inc. ($GH) Insider: Roberto Mignone (Director) Transaction: Acquired 264 Common Shares via RSU vesting (Transaction Code: M) at $0.00. Total Post-Transaction Ownership: 10,538 direct shares (+ 6,336 remaining RSUs). Significance: Low (Routine vesting under standard compensation schedule).

Comprehensive Analysis

Guardant Health, Inc. ($GH) Form 4 Analysis

Transaction Overview

On October 21, 2026, Guardant Health Director Roberto Mignone acquired 264 shares of Common Stock upon the vesting of restricted stock units (RSUs) granted on November 8, 2024. The acquisition was executed at $0.00 per share pursuant to standard vesting terms, bringing his direct common shareholdings to 10,538 shares.

Key Details

  • Insider: Roberto Mignone (Director)
  • Transaction Code: M (Exercise or conversion of derivative security)
  • Shares Acquired: 264 shares
  • Execution Price: $0.00
  • Gross Value: $0.00
  • Post-Transaction Holdings: 10,538 common shares held directly, with 6,336 unvested RSUs remaining.

Trading Significance

This transaction carries Low trading significance as it represents standard equity compensation vesting rather than discretionary open-market buying or selling.

Topics:#GuardantHealth#GH#InsiderTrading#Form4#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.